Obstet Gynecol 1998; 178:765.
74 74. Lambotte R, Uhlenbruck G. Amniomucoids – a new class of hexosamine‐rich glycoproteins. Nature 1966; 212:290.
75 75. Lambotte R, Gosselin‐Ray C. Analyse électrophorétique de la teneur en polysaccharides de l'α1 globuline spécifique au liquide amniotique humain. Arch Int Physiol Biochim Biophys 1967; 75:109.
76 76. Chitayat D, Marion RW, Squillante L, et al. Detection and enumeration of colonic mucosal cells in amniotic fluid using a colon epithelial‐specific monoclonal antibody. Prenat Diagn 1990; 10:725.
77 77. Friel LA, Romero R, Edwin S, et al. The calcium binding protein, S100B, is increased in the amniotic fluid of women with intra‐amniotic infection/inflammation and preterm labor with intact or ruptured membranes. J Perinat Med 2007; 35:385.
78 78. Tskitishvili E, Komoto Y, Temma‐Asano K, et al. S100B protein expression in the amnion and amniotic fluid in pregnancies complicated by pre‐eclampsia. Mol Hum Reprod 2006; 12:755.
79 79. Florio P, Michetti F, Bruschettini M, et al. Amniotic fluid S100B protein in mid‐gestation and intrauterine fetal death. Lancet 2004; 364:270.
80 80. Cho CK, Shan SJ, Winsor EJ, et al. Proteomics analysis of human amniotic fluid. Mol Cell Proteomics 2007; 6:1406.
81 81. Michaels JE, Dasari S, Pereira L, et al. Comprehensive proteomic analysis of the human amniotic fluid proteome: gestational age‐dependent changes. J Proteome Res 2007; 6:1277.
82 82. Buhimschi CS, Buhimschi IA, Abdel‐Razeq S, et al. Proteomic biomarkers of intra‐amniotic inflammation: relationship with funisitis and early‐onset sepsis in the premature neonate. Pediatr Res 2007; 61:318.
83 83. Buhimschi IA, Zhao G, Rosenberg VA, et al. Multidimensional proteomics analysis of amniotic fluid to provide insight into the mechanisms of idiopathic preterm birth. PLoS One 2008; 3:e2049.
84 84. Kamath‐Rayne BD, Smith HC, Muglia LJ, et al. Amniotic fluid: the use of high‐dimensional biology to understand fetal well‐being. Reprod Sci 2014; 21:6.
85 85. Wang TH, Chang YL, Peng HH, et al. Rapid detection of fetal aneuploidy using proteomics approaches on amniotic fluid supernatant. Prenat Diagn 2005; 25:559.
86 86. Hassan MI, Kumar V, Singh TP, et al. Proteomic analysis of human amniotic fluid from Rh(−) pregnancy. Prenat Diagn 2008; 28:102.
87 87. Biezenski JJ. Incorporation of 14C‐1‐palmitate into rabbit fetal lipids in vivo. Am J Obstet Gynecol 1976; 126:356.
88 88. Robertson AF, Sprecher H. A review of human placental lipid metabolism and transport. Acta Paediatr Scand 1968:Suppl 183:3.
89 89. Pomerance W, Biezenski JJ, Moltz A, et al. Origin of amniotic fluid lipids. II. Abnormal pregnancy. Obstet Gynecol 1971; 38:379.
90 90. Gardella C, Hitti J, Martin TR, et al. Amniotic fluid lipopolysaccharide‐binding protein and soluble CD14 as mediators of the inflammatory response in preterm labor. Am J Obstet Gynecol 2001; 184:1241.
91 91. Dallaire L, Mitchell G, Giguere R, et al. Prenatal diagnosis of Smith‐Lemli‐Opitz syndrome is possible by measurement of 7‐dehydrocholesterol in amniotic fluid. Prenat Diagn 1995; 15:855.
92 92. Tint GS, Abuelo D, Till M, et al. Fetal Smith‐Lemli‐ Opitz syndrome can be detected accurately and reliably by measuring amniotic fluid dehydrocholesterols. Prenat Diagn 1998; 18:651.
93 93. Wassif CA, Maslen C, Kachilele‐Linjewile S, et al. Mutations in the human sterol delta7‐reductase gene at 11q12‐13 cause Smith‐Lemli‐Opitz syndrome. Am J Hum Genet 1998; 63:55.
94 94. Loeffler J, Utermann G, Witsch‐Baumgartner M. Molecular prenatal diagnosis of Smith‐Lemli‐Opitz syndrome is reliable and efficient. Prenat Diagn 2002; 22:827.
95 95. Waye JS, Eng B, Nowaczyk MJ. Prenatal diagnosis of Smith‐Lemli‐Opitz syndrome (SLOS) by DHCR7 mutation analysis. Prenat Diagn 2007; 27:638.
96 96. Shinawi M, Szabo S, Popek E, et al. Recognition of Smith‐Lemli‐Opitz syndrome (RSH) in the fetus: utility of ultrasonography and biochemical analysis in pregnancies with low maternal serum estriol. Am J Med Genet A 2005; 138:56.
97 97. Chevy F, Humbert L, Wolf C. Sterol profiling of amniotic fluid: a routine method for the detection of distal cholesterol synthesis deficit. Prenat Diagn 2005; 25:1000.
98 98. Fitzky BU, Witsch‐Baumgartner M, Erdel M, et al. Mutations in the Delta7‐sterol reductase gene in patients with the Smith‐Lemli‐Opitz syndrome. Proc Natl Acad Sci U S A 1998; 95:8181.
99 99. Yu H, Lee MH, Starck L, et al. Spectrum of delta(7)‐dehydrocholesterol reductase mutations in patients with the Smith‐Lemli‐Opitz (RSH) syndrome. Hum Mol Genet 2000; 9:1385.
100 100. Yu H, Tint GS, Salen G, et al. Detection of a common mutation in the RSH or Smith‐Lemli‐Opitz syndrome by a PCR‐RFLP assay: IVS8‐G→C is found in over sixty percent of US propositi. Am J Med Genet 2000; 90:347.
101 101. Haas D, Haege G, Hoffmann GF, et al. Prenatal presentation and diagnostic evaluation of suspected Smith‐Lemli‐Opitz (RSH) syndrome. Am J Med Genet A 2013; 161A:1008.
102 102. Goldenberg A, Wolf C, Chevy F, et al. Antenatal manifestations of Smith‐Lemli‐Opitz (RSH) syndrome: a retrospective survey of 30 cases. Am J Med Genet A 2004; 124A:423.
103 103. Hagenfeldt L, Hagenfeldt K. Individual free fatty acids in amniotic fluid and in plasma of pregnant women. Br J Obstet Gynaecol 1976; 83:383.
104 104. Rueda R, Vargas ML, Garcia‐Pacheco M, et al. Detection of immunoregulatory lipid‐like factors in human amniotic fluid. Am J Reprod Immunol 1990; 24:40.
105 105. Heikkinen J, Maentausta O, Tuimala R, et al. Amniotic fluid bile acids in normal and pathologic pregnancy. Obstet Gynecol 1980; 56:60.
106 106. Deleze G, Sidiropoulos D, Paumgartner G. Determination of bile acid concentration in human amniotic fluid for prenatal diagnosis of intestinal obstruction. Pediatrics 1977; 59:647.
107 107. Shrand H. Vomiting in utero with intestinal atresia. Pediatrics 1972; 49:767.
108 108. Gluck L, Kulovich MV. Lecithin‐sphingomyelin ratios in amniotic fluid in normal and abnormal pregnancy. Am J Obstet Gynecol 1973; 115:539.
109 109. Gluck L. Surfactant: 1972. Pediatr Clin North Am 1972; 19:325.
110 110. Briand RL, Harold S, Blass KG. High‐performance liquid chromatographic determination of the lecithin/sphingomyelin ratio in amniotic fluid. J Chromatogr 1981; 223:277.
111 111. Ghidini A, Poggi SH, Spong CY, et al. Role of lamellar body count for the prediction of neonatal respiratory distress syndrome in non‐diabetic pregnant women. Arch Gynecol Obstet 2005; 271:325.
112 112. Karcher R, Sykes E, Batton D, et al. Gestational age specific predicted risk of neonatal respiratory distress syndrome using lamellar body count and surfactant‐to‐albumin ratio in amniotic fluid. Am J Obstet Gynecol 2005; 193:1680.
113 113. ACOG Committee opinion no. 560: Medically indicated late‐preterm and early‐term deliveries. Obstet Gynecol 2013; 121:908.
114 114. Damron DP. Fetal lung maturity testing. Am J Obstet Gynecol 2014; 211:184.
115 115. Southren AL, Kobayashi Y, Brenner P, et al. Diamine oxidase activity in human maternal and fetal plasma and tissues at parturition. J Appl Physiol 1965; 20:1048.
116 116. Lapan B, Friedman MM. Enzymes in the amniotic fluid and maternal serum. A comparative study. Am J Obstet Gynecol 1962; 83:1337.
117 117. Usategui‐Gomez M. Immunoglobulins and other proteins in amniotic fluid. In: Natelson S, Scommegna A, Epstein MB, eds. Amniotic fluid. New York: Wiley, 1974:111.
118 118. Uuspaa VJ. High histaminase activity of human blood in pregnancy and the so‐called placenta haemochorialis: preliminary report. Ann Med Exp Biol Fenn 1951; 29:81.
119 119. Kerenyi T, Sarkozi L. Diagnosis of fetal death in utero by elevated amniotic fluid CPK levels. Obstet Gynecol 1974; 44:215.
120 120.